Clinical Trial Update: Evaluation of Peginterferon Alfa-2b Monotherapy and Combination With Ribavirin in Participants With Acute Hepatitis C (P03552/MK-4031-137) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating peginterferon alfa-2b as monotherapy and in combination with ribavirin for acute hepatitis C has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• PegIntron (pegylated interferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C | Phase 3 | Status: COMPLETED | Results posted: 2012-01-31